Daily Big Picture – Nifty ends 0.5% Higher led by IT Stocks, Nifty Pharma in Correction

Today’s Action

Benchmark indices continued their gains on Tuesday. Nifty, +0.5%, Sensex, +0.5%, Model Portfolio, +1.1%.; MSI Ind 47, +0.5%.

Daily Market Review

India’s benchmark indices continued to rally for the second day of the ongoing week. Nifty PSU Bank (+1.0%) continued its positive streak along with Nifty IT (+1.4%). However, Nifty Pharma (-1.3%) was the worst performer dragged down by losses in Sun Pharm.Industries and Piramal Enterprises. Nifty Metal (-0.7%) also ended in red led by steel companies. We downgraded Nifty Pharma from a Rally Attempt to a Downtrend as it fell to a new low today.

Nifty Midcap and Smallcap gained 0.5% and 0.6%, respectively.

Though Nifty was up 0.5%, the advance-decline ratio was in favor of decliners. Of the 2,059 stocks traded on the NSE, 792 gained, 921 declined, and 346 remained unchanged.

The market status remains unchanged at a Confirmed Uptrend. The distribution count stands at two on the Nifty. We suggest investors to track fundamentally strong stocks trading above their 50- and 200-DMA and take positions on strong breakouts. Investors should begin with a smaller allocation and increase it gradually as market displays positive signals like additional follow-through days.

Stocks in News

Sun Pharm.Industries opened 2% higher as the Company announced on Monday that it has, along with its subsidiaries, entered into settlements with certain plaintiffs in the U.S. However the stock plunged 7% as the day progressed and closed 3.3% lower.

Reliance Capital closed 1.6% up ahead of its quarterly results which are to be announced today.

Ifci received Rs 491.8 crores (net of TDS) as a result of resolution proceedings on Binani Cement under the purview of NCLT. The stock ended 2.9% higher today.

Action in Leading Stocks

Leaders Up on Volume: Iol Chemicals & Pharms. (+9.4%), Vip Industries (+7.7%), and Astrazeneca Pharma India (+5.9%)

Leaders Down on Volume: None

To Read Detailed Reports including Stock Recommendations, Idea Lists, Evaluate Stocks etc. Subscribe to  MarketSmith India.

Leave a Reply

Your email address will not be published. Required fields are marked *